|
NOM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4544810628413E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28361773935148E-12 |
| Normal-vs-Stage2 |
4.033900E-04 |
| Normal-vs-Stage3 |
2.581000E-04 |
| Normal-vs-Stage4 |
8.08380000000275E-05 |
| Stage1-vs-Stage2 |
6.781200E-01 |
| Stage1-vs-Stage3 |
3.452200E-02 |
| Stage1-vs-Stage4 |
1.950990E-01 |
| Stage2-vs-Stage3 |
3.144000E-01 |
| Stage2-vs-Stage4 |
5.745200E-01 |
| Stage3-vs-Stage4 |
6.069200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11950004821892E-10 |
| Normal-vs-AfricanAmerican |
2.57599999997637E-06 |
| Normal-vs-Asian |
9.297300E-03 |
| Caucasian-vs-AfricanAmerican |
1.501190E-01 |
| Caucasian-vs-Asian |
5.027300E-04 |
| AfricanAmerican-vs-Asian |
1.139930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.40299996462556E-09 |
| Normal-vs-Female |
1.92124094411383E-12 |
| Male-vs-Female |
2.778000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.159900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.0009993662029E-11 |
| Normal-vs-Age(61-80Yrs) |
5.84310000384392E-09 |
| Normal-vs-Age(81-100Yrs) |
1.066190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.555800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.859600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.902800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.425800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.070400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.960400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.016300E-03 |
| Normal-vs-Grade 2 |
1.03349551139331E-11 |
| Normal-vs-Grade 3 |
1.47640000003335E-07 |
| Normal-vs-Grade 4 |
8.565200E-04 |
| Grade 1-vs-Grade 2 |
6.668300E-02 |
| Grade 1-vs-Grade 3 |
8.016400E-02 |
| Grade 1-vs-Grade 4 |
2.448400E-02 |
| Grade 2-vs-Grade 3 |
7.676400E-02 |
| Grade 2-vs-Grade 4 |
1.647410E-01 |
| Grade 3-vs-Grade 4 |
8.723800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.33759670006839E-11 |
| Normal-vs-ccB subtype |
1.78520000004845E-07 |
| ccA subtype-vs-ccB subtype |
2.320200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95250054907592E-10 |
| Normal-vs-N1 |
3.478000E-02 |
| N0-vs-N1 |
6.744600E-01 |
|
|
